All-Cash Masimo Deal Offers Strong Strategic Fit For Danaher Corporation (DHR)

Danaher Corporation (NYSE:DHR) is one of the 10 best life sciences stocks to buy according to hedge funds. On February 17, Danaher Corporation (NYSE:DHR) announced an agreement to acquire Masimo Corporation (NASDAQ:MASI) for nearly $9.9 billion. In the all-cash deal, Danaher will acquire 100% of the common shares outstanding at $180 per share. This translates into 2027 forecasted EBITDA multiples of 15x and 18x, with and without potential synergies, respectively. All-Cash Masimo Deal Offers Strong Strate ...